Forty-eight Arizona business leaders signed on to a letter delivered on July 22, 2022 to Arizona’s Congressional Delegation emphasizing the importance of reauthorizing the SBIR/STTR program.
The letter, was signed by business leaders from: Arizona Bioindustry Association, Inc. (AZBio), Arizona Chamber of Commerce & Industry, Arizona Commerce Authority, Arizona Technology Council, Desert Angels, Inc., Greater Phoenix Chamber, Greater Phoenix Economic Council, Greater Phoenix Leadership, PHX East Valley Partnership, Southern Arizona Leadership Council (SALC), Tucson Metro Chamber, UAVenture Capital, University of Arizona, AdviNow Medical, Aesthetics Biomedical, Inc., Aqualung Therapeutics, Anuncia Medical, Inc., Beacon Biomedical, Becton Dickinson (BD), Biosensing Instrument, Inc., bioSyntagma, Inc., Calviri, Inc., Dignity Health, EthiX Associates, Exact Sciences, GT Medical Technologies, Inc., HonorHealth Research & Innovation Institute, Humabiologics, Inc., Langham Logistics, Inc., Mayo Clinic, Metfora, Microvascular Therapeutics, Navi Nurses, NuvOx Pharma, nVector, Plaza Companies, Regenesis Biomedical, Inc., Regional Center for Border Health, Inc.,
ReSuture Inc., SARRC, Scintillation Nanotechnologies, Inc., Sequitur Health Corp., SpencerFane, Translational Sciences, Inc.,
VMAS Solutions, Inc. (dba TouchPoint Solution), and Yelton and Associates.Continue reading